1461 related articles for article (PubMed ID: 15146184)
1. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.
Ravikumar B; Vacher C; Berger Z; Davies JE; Luo S; Oroz LG; Scaravilli F; Easton DF; Duden R; O'Kane CJ; Rubinsztein DC
Nat Genet; 2004 Jun; 36(6):585-95. PubMed ID: 15146184
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies.
Sarkar S; Ravikumar B; Floto RA; Rubinsztein DC
Cell Death Differ; 2009 Jan; 16(1):46-56. PubMed ID: 18636076
[TBL] [Abstract][Full Text] [Related]
3. A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin.
Sarkar S; Krishna G; Imarisio S; Saiki S; O'Kane CJ; Rubinsztein DC
Hum Mol Genet; 2008 Jan; 17(2):170-8. PubMed ID: 17921520
[TBL] [Abstract][Full Text] [Related]
4. Huntingtin aggregates ask to be eaten.
Thoreen CC; Sabatini DM
Nat Genet; 2004 Jun; 36(6):553-4. PubMed ID: 15167929
[No Abstract] [Full Text] [Related]
5. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein.
Sarkar S; Davies JE; Huang Z; Tunnacliffe A; Rubinsztein DC
J Biol Chem; 2007 Feb; 282(8):5641-52. PubMed ID: 17182613
[TBL] [Abstract][Full Text] [Related]
6. Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice.
Zheng S; Clabough EB; Sarkar S; Futter M; Rubinsztein DC; Zeitlin SO
PLoS Genet; 2010 Feb; 6(2):e1000838. PubMed ID: 20140187
[TBL] [Abstract][Full Text] [Related]
7. Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy.
Ravikumar B; Stewart A; Kita H; Kato K; Duden R; Rubinsztein DC
Hum Mol Genet; 2003 May; 12(9):985-94. PubMed ID: 12700167
[TBL] [Abstract][Full Text] [Related]
8. Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease.
Rose C; Menzies FM; Renna M; Acevedo-Arozena A; Corrochano S; Sadiq O; Brown SD; Rubinsztein DC
Hum Mol Genet; 2010 Jun; 19(11):2144-53. PubMed ID: 20190273
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin pre-treatment protects against apoptosis.
Ravikumar B; Berger Z; Vacher C; O'Kane CJ; Rubinsztein DC
Hum Mol Genet; 2006 Apr; 15(7):1209-16. PubMed ID: 16497721
[TBL] [Abstract][Full Text] [Related]
10. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy.
Ravikumar B; Duden R; Rubinsztein DC
Hum Mol Genet; 2002 May; 11(9):1107-17. PubMed ID: 11978769
[TBL] [Abstract][Full Text] [Related]
11. Huntington's disease: degradation of mutant huntingtin by autophagy.
Sarkar S; Rubinsztein DC
FEBS J; 2008 Sep; 275(17):4263-70. PubMed ID: 18637946
[TBL] [Abstract][Full Text] [Related]
12. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.
Huang CC; Faber PW; Persichetti F; Mittal V; Vonsattel JP; MacDonald ME; Gusella JF
Somat Cell Mol Genet; 1998 Jul; 24(4):217-33. PubMed ID: 10410676
[TBL] [Abstract][Full Text] [Related]
13. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease.
Tanaka M; Machida Y; Niu S; Ikeda T; Jana NR; Doi H; Kurosawa M; Nekooki M; Nukina N
Nat Med; 2004 Feb; 10(2):148-54. PubMed ID: 14730359
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of Drosophila Apaf-1 related killer suppresses formation of polyglutamine aggregates and blocks polyglutamine pathogenesis.
Sang TK; Li C; Liu W; Rodriguez A; Abrams JM; Zipursky SL; Jackson GR
Hum Mol Genet; 2005 Feb; 14(3):357-72. PubMed ID: 15590702
[TBL] [Abstract][Full Text] [Related]
15. Conophylline protects cells in cellular models of neurodegenerative diseases by inducing mammalian target of rapamycin (mTOR)-independent autophagy.
Sasazawa Y; Sato N; Umezawa K; Simizu S
J Biol Chem; 2015 Mar; 290(10):6168-78. PubMed ID: 25596530
[TBL] [Abstract][Full Text] [Related]
16. Induction of autophagy with catalytic mTOR inhibitors reduces huntingtin aggregates in a neuronal cell model.
Roscic A; Baldo B; Crochemore C; Marcellin D; Paganetti P
J Neurochem; 2011 Oct; 119(2):398-407. PubMed ID: 21854390
[TBL] [Abstract][Full Text] [Related]
17. Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.
Nguyen T; Hamby A; Massa SM
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11840-5. PubMed ID: 16087879
[TBL] [Abstract][Full Text] [Related]
18. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release.
Jana NR; Zemskov EA; Wang Gh ; Nukina N
Hum Mol Genet; 2001 May; 10(10):1049-59. PubMed ID: 11331615
[TBL] [Abstract][Full Text] [Related]
19. Huntingtin processing in pathogenesis of Huntington disease.
Qin ZH; Gu ZL
Acta Pharmacol Sin; 2004 Oct; 25(10):1243-9. PubMed ID: 15456523
[TBL] [Abstract][Full Text] [Related]
20. Arfaptin 2 regulates the aggregation of mutant huntingtin protein.
Peters PJ; Ning K; Palacios F; Boshans RL; Kazantsev A; Thompson LM; Woodman B; Bates GP; D'Souza-Schorey C
Nat Cell Biol; 2002 Mar; 4(3):240-5. PubMed ID: 11854752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
